BusinessApricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by RecordatiBy Nasdaq OMXSep 21, 2016, 11:00 AM UTC
BusinessApricus Biosciences Announces Completion of Transfer of the Marketing Authorizations for Vitaros® in Finland and Denmark to Ferring PharmaceuticalsBy Nasdaq OMXSep 20, 2016, 11:01 AM UTC
BusinessApricus Biosciences Announces Approval of Vitaros® for the Treatment of Erectile Dysfunction in ArgentinaBy Nasdaq OMXSep 8, 2016, 11:00 AM UTC
BusinessAlphatec Holdings Completes Sale of International Business to Globus MedicalBy Nasdaq OMXSep 1, 2016, 8:22 PM UTC
BusinessPosten Norge selects Gemalto ID Verification to strengthen fraud protection for NorwayBy Nasdaq OMXSep 1, 2016, 5:00 AM UTC
BusinessBank of the Philippines Islands teams up with Gemalto to combine Banking and Transport into one prepaid cardBy Nasdaq OMXAug 30, 2016, 5:00 AM UTC
BusinessChembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika VirusBy Nasdaq OMXAug 25, 2016, 1:53 PM UTC
BusinessCancer Genetics, Inc. Reports Second Quarter 2016 Financial Results and Provides Company UpdatesBy Nasdaq OMXAug 9, 2016, 10:59 PM UTC
